- Home
- INTT vs AVTX Comparison
INTT vs AVTX Comparison
Compare INTT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTT | AVTX |
|---|---|---|
| Founded | 1981 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.4M | 888.6M |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | INTT | AVTX |
|---|---|---|
| Price | $11.97 | $14.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | $19.67 | ★ $44.08 |
| AVG Volume (30 Days) | 90.0K | ★ 926.6K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $66,801,000.00 | $27,813,137.00 |
| Revenue This Year | $21.53 | N/A |
| Revenue Next Year | $7.05 | N/A |
| P/E Ratio | $193.83 | ★ N/A |
| Revenue Growth | 66.06 | ★ 2312.27 |
| 52 Week Low | $7.07 | $12.51 |
| 52 Week High | $20.00 | $24.27 |
Technical Indicators
Market Signals| Indicator | INTT | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 37.58 |
| Support Level | $11.17 | $15.11 |
| Resistance Level | $11.83 | $20.54 |
| Average True Range (ATR) | 0.47 | 0.82 |
| MACD | 0.18 | -0.06 |
| Stochastic Oscillator | 88.82 | 32.95 |
Price Performance
Historical ComparisonAbout INTT inTest Corporation
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.